CD44 and prostate cancer: Cell cycle arrest and inhibition of the survival, proliferation, and migration of PC3 cells expressing CD44 and CD133 isolated from prostate cancer by inhibiting p‐p38, p‐ERK, NF‐κB, and PARP.200